The analysis also discusses the regulatory alternatives FDA considered in drafting the proposed rule.
The analysis does not discuss the regulatory alternatives FDA considered in drafting the proposed rule.
mnli hypothesis: The analysis does not discuss the regulatory alternatives FDA considered in drafting the proposed rule. premise: The analysis also discusses the regulatory alternatives FDA considered in drafting the proposed rule.